India  

Adar Poonawalla

Indian businessman

Adar Poonawalla    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Adar Poonawalla: Indian businessman
Adar Poonawalla is an Indian businessman. He is the chief executive officer (CEO) of Serum Institute of India Founded in 1966 by his father, Cyrus Poonawalla, it is the world's largest vaccine manufacturer by number of doses produced. He is also the Chairman of Poonawalla Fincorp.

0
shares
ShareTweetSavePostSend
 

You Might Like


'Elderly people can...': SII's CEO Adar Poonawalla's big remark on Covid spike in India

India has recorded 12,193 fresh Covid-19 cases in 24 hours. The number of active cases climbed to 67,556.
DNA - Published

Covovax for adults to reach metros in a week: SII

Serum Institute of India’s CEO Adar Poonawalla told TOI on Friday that doses of Covovax — Covid booster shot for adults — would reach major cities in four to five days, while a Bharat Biotech..
IndiaTimes - Published

SII to restart vaccine production amid surge in Covid cases

Serum Institute of India CEO Adar Poonawalla told TOI on Wednesday that the company has resumed production of its Covid-19 vaccine, Covishield, in response to the increasing number of SARS-CoV-2 virus..
IndiaTimes - Published

Serum Institute of India restarts manufacturing of Covid-19 vaccine Covishield

Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of cases of the virus infection. He said the..
IndiaTimes - Published

India well-prepared to combat any future waves: SII CEO Adar Poonawalla amid Covid scare in China


IndiaTimes - Published

Covovax vaccine to get booster dose approval in 10-15 days: SII CEO Adar Poonawalla


IndiaTimes - Published

Covid situation in India better than elsewhere: SII CEO Adar Poonawalla

Serum Institute CEO Adar Poonawalla on Sunday lauded India's fight against the Covid pandemic, saying the government and the healthcare workers contributed largely to tackling the pandemic. "Everyone..
IndiaTimes - Published

News of rising covid cases coming out of China is concerning: Adar Poonawalla

Covid has made a comeback in China and the world is worried about its spread. Adar Poonawalla of the SII has spoken about it.
DNA - Published

HPV vaccine production delayed due to Covid focus, will start supply to Indian govt in early 2023: SII

Serum Institute of India (SII) had to defer HPV vaccine production by two years due to the focus on Covid, and will start supplying small quantities of the dose to the Indian government in early 2023,..
IndiaTimes - Published

What exactly Udit Raj said about President Droupadi Murmu and why? Sambit Patra, Shehzad Poonawalla slam Congress leader

Launching a scathing attack, Poonawalla said this was the real face of the Congress.
DNA - Published

SII's Adar Poonawalla makes clarion call for global certification of vaccines

"Multilateral organisations such as the United Nations and the World Trade Organisation should take it upon themselves to harmonise the certification of vaccines," Adar Poonawalla told PTI on the..
IndiaTimes - Published

Scammers send fake message in CEO Adar Poonawalla's name, dupe Serum Institute of Rs 1 crore

Fraudsters allegedly attempted to con one of SII's directors by sending him a WhatsApp message asking him to wire money to numerous other accounts.
DNA - Published

Cost of cervical cancer vaccine set to be Rs 200-400

Cervavac, India's first indigenously developed vaccine for preventing cervical cancer caused by Human Papilloma Virus (HPV), is likely to be priced between Rs 200-400 per dose, Serum Institute of India..
IndiaTimes - Published

Cervical cancer vaccine to be launched in few months, know price, launch date

Poonawalla said the vaccine will be possibly launched by the end of the year.
DNA - Published

SII will try to launch Omicron-specific vaccine after six months: Adar Poonawalla


IndiaTimes - Published Also reported by •DNA

Vaccine for Omicron likely in 6 months: SII’s Poonawala

The vaccine will be specific to the BA5 sub-variant of the Omicron strain, SII CEO Adar Poonawalla told a TV channel, adding that he thought “this vaccine is important as a booster”.
IndiaTimes - Published

Serum Institute of India to launch indigenously made vaccine to treat cervical cancer

Serum Institute of India CEO Adar Poonawalla on Tuesday said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year.
IndiaTimes - Published

Covid-19 vaccine Covovax now available for children in India: Adar Poonawalla

Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said that the Covid-19 vaccine Covovax is now available in India for children. He also hailed PM Narendra Modi for his vision of providing..
IndiaTimes - Published

Covid 4th wave: Adar Poonawalla warns against 'business as usual' approach amid rising cases

Though the government, as a whole, recognises the importance of healthcare, it seems the urgency has been lost, Adar Poonawalla said.
DNA - Published

Indian Covid vaccines better than Pfizer, Moderna: Adar Poonawalla

Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that "Made in India" Covid vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and..
IndiaTimes - Published

Reduce time gap for Covid vaccine booster dose to six months: Serum Institute to govt

Vaccine major Serum Institute of India (SII) has appealed to the government to reduce the gap between the second and booster dose to six months from nine months at present to safeguard people against..
IndiaTimes - Published

Serum Institute of India prices Covishield booster dose at Rs 600

SII CEO Adar Poonawalla also welcomed the government's move to allow precautionary doses of the vaccine to all aged above 18 years.
DNA - Published

Serum Institute has applied for full market authorisation of Covishield: CEO Adar Poonawala

Serum Institute has applied to the Indian health ministry and Central Drugs Standard Control Organisation (CDSCO) for full market authorisation for its Covishield vaccine, company's CEO Adar Poonawalla..
IndiaTimes - Published

SII CEO Adar Poonawalla makes BIG announcement on COVID-19 vaccine for children

Serum Institute's CEO Adar Poonawalla has said that the vaccine for children will most likely be launched within six months.
DNA - Published

Not enough orders, may cut Covishield output by 50%: SII

With not enough orders for Covishield from the Centre, Serum Institute of India CEO Adar Poonawalla on Tuesday said the company is looking at slashing monthly production of vaccines by at least 50% %...
IndiaTimes - Published

How effective is Covishield against Omicron? SII CEO Adar Poonawalla says this

In India, no cases of the new variant have been detected yet, but the government says it is preparing to deal with it.
DNA - Published

'Vaccine hesitancy biggest threat': SII CEO Adar Poonawalla on COVID-19

The government will soon launch a door-to-door vaccination campaign so that no adults are left of vaccination and are covered by next month.
DNA - Published

Covid-19 vaccine hesitancy greatest threat in overcoming pandemic, says Adar Poonawalla


IndiaTimes - Published